Document is current
Any future updates will be listed below
-
Authors
von Linstow, Marie-Louise
Rudolfsen, Jan Håkon
Olsen, Jens
Skovdal, Mette
Staerke, Nina Breinholt
-
Funding
Funding for this research was provided by:
Pfizer Denmark, Denmark
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 23 September 2024
First Online: 3 October 2024
Declarations
:
: The study was register based and complied with the regulations and instructions established by Statistics Denmark. We used anonymised data and present data only in aggregate and anonymous form. We did not contact or require any active participation from study participants. Ethics committee approval and written informed consent are not required for register-based research, according to Danish law [,].
: Not applicable.
: Jan Håkon Rudolfsen and Jens Olsen are employees at EY, which is a paid vendor of Pfizer Denmark ApS. Nina Breinholt Stærke and Marie-Louise von Linstow were paid by Pfizer Denmark ApS for their work as a member of the study steering committee. Nina Breinholt Stærke served as principal investigator on clinical studies investigating RSV vaccines sponsored by Pfizer and Moderna. The authors report no other conflicts of interest in this work. Mette Skovdal is employee of Pfizer Denmark ApS and owns shares in Pfizer Inc.
